baber/WOPTO huggingface dataset:
Patent NZ-531219-A (NZ)
Title: Antibody glycosylation variants having increased antibody-dependent cellular cytotoxicity
Inventor: BAILEY JAMES E
IPC: C12N5/06
Filed: 2002-08-05
Abstract: Disclosed is the use of an antibody for the preparation of a pharmaceutical composition for the treatment of cancer, wherein the antibody specifically binds the human G250 antigen, wherein the antibody has been glycoengineered to have an increased proportion of bisected hybrid oligosaccharides or galactosylated complex oligosaccharides in the Fc region, and wherein the antibody has increased antibody-dependent cellular cytotoxicity as a result of the glycoengineering.
Patent NZ-531387-A (NZ)
Title: Pipe joint safety inspection device
Inventor: VAN KEEKEN RENE
IPC: F16L23/00
Filed: 2002-08-28
Abstract: An inspection device for use on joint zones of piping (4) and the like where the joint zone (2) includes a joint interface (3a), the device comprising a housing (1) adapted for fitting over the joint interface so as to form a substantial seal bridging the joint interface wherein the housing is adapted to allow visual or other inspection of the joint interface.
Patent NZ-533211-A (NZ)
Title: Index structure of metadata, method for providing indices of metadata, and metadata searching method and apparatus using the indices of metadata
Inventor: SHIN HYOSEOP
IPC: G06F17/30
Filed: 2003-07-16
Abstract: A method of providing an index structure for metadata divided into fragments comprises providing a list of keys corresponding to fields of the metadata and location information for defining a key of the list wherein at least part of the location information is expressed as a predetermined code. A method of providing an index structure for metadata divided into fragments comprises: providing a key index key list section comprising a list of keys corresponding to fields of the metadata and location information defining the keys wherein at least part of the location information is expressed as a predetermined code; providing a key index section and providing a sub key index section wherein for a key of the key index the sub key index comprises a range of values of the key and identification information on the ones of the fragments of metadata corresponding to the values of the key and the key index section comprises representative key values representing the representative ranges of values of the key. (62) Divided out of 533162
Patent NZ-534802-A (NZ)
Title: Purification of red blood cells by separation of defibrinated whole blood and diafiltration
Inventor: HOUTCHENS ROBERT A
Filed: 2002-02-28
Abstract: Red blood cells are purified by separating defibrinated whole blood, such as by centrifugation, to form a red blood cell fraction and a liquid fraction. Preferably, the whole blood is bovine blood. The red blood cell fraction is then diafiltered to purify the red blood cells. The purified red blood cells can then be lysed to form a lysate of purified red blood cells. The purified red blood cells and the lysate of purified red blood cells are suitable for use in producing hemoglobin blood substitute.
Patent NZ-534926-A (NZ)
Title: Fungicidal mixtures based on prothioconazole, containing fenpropiomorph, tridemorph or fenpropidin
Inventor: AMMERMANN EBERHARD
IPC: A01N25/08
Filed: 2003-02-26
Abstract: A fungicidal mixture containing (1) 2-[2-(1-chlorocyclopropyl)-3-(2-chlorophenyl)-2-hydroxypropyl]-2,4-dihydro-[1,2,4]-triazole-3-thione (prothioconazoles) of formula I or the salts or adducts thereof and at least one additional fungicide or salts or adducts thereof, selected from (2) fenpropiomorph of formula II and (3) tridemorph of formula III wherein n = 10, 11, 12, (60 - 70 %) or 13, and (4) fenpropidin of formula IV in a synergistically effective amount.
Patent NZ-541829-A (NZ)
Title: Non-nucleoside reverse transcriptase inhibitors I for treating HIV mediated diseases
Inventor: DUNN JAMES PATRICK
IPC: A61P31/18
Filed: 2004-03-22
Abstract: Disclosed is a compound according to formula I wherein the substituents are disclosed within the specification and hydrates, solvates, clathrates and acid addition salts thereof. Also disclosed is the use of the above compound for the preparation of a medicament for treating an HIV infection, or preventing an HIV infection, or treating AIDS or ARC.
Patent NZ-542111-A (NZ)
Title: Novel assay
Inventor: CARDNO TONY STUART
Filed: 2005-08-30
Abstract: Disclosed is a translational recoding reporter construct comprising: a) a first fluorescent protein coding sequence, b) a second fluorescent protein coding sequence encoding a fluorescent protein different from the first fluorescent protein; and c) a linker sequence interposed between the first and second fluorescent protein coding sequence; wherein the first fluorescent protein coding sequence and the second fluorescent protein coding sequence are out-of-frame with respect to each other but are co-expressed as a single fusion polypeptide upon recoding, and wherein the linker sequence encodes a polypeptide capable of physically separating the co-expressed fluorescent proteins, resulting in increased fluorescence output from each protein. Also disclosed are methods of use of the construct in screening modulators of recoding.
Patent NZ-542715-A (NZ)
Title: System and method for storing and accessing data in an interlocking trees datastore
Inventor: MAZZAGATTI JANE CAMPBELL
IPC: G06F17/00
Filed: 2004-02-27
Abstract: A system for generating a datastore is disclosed. The system comprises: a processor; a memory coupled to the processor; and a datastore generator for creating a datastore. The datastore comprises: root nodes and non-root nodes, organized into a plurality of connected trees, where the plurality of connected trees comprise a tree of a first type comprising a first root and at least one of a plurality of non-root nodes, and at least one of a plurality of trees of a second type. The second tree type comprises a second root node and a plurality of non-root nodes common with the nodes of the tree of the first type, wherein the nodes of the datastore include at least one elemental node, one subcomponent node and one end product node. At least one elemental node comprises a first null pointer, a second null pointer, a third null pointer and a fourth pointer pointing to a second list of pointers to nodes, the second list comprising nodes which contain the elemental node as their second portion.
Patent NZ-545593-A (NZ)
Title: Transdermal pharmaceutical preparation comprising L-dopa or a dopamine agonist, and an anticholinerically active substance or an NMDA receptor agonist, for treating ParkinsonÆs disease
Inventor: HORSTMANN MICHAEL
IPC: A61P25/16
Filed: 2004-08-14
Abstract: Disclosed is a transdermal pharmaceutical preparation, for the treatment of Parkinson's disease, comprising a combination of at least two active substances, wherein the first is selected from L-dopa and a dopamine agonist, and the second is selected from an anticholinergically active substance and an NMDA receptor antagonist.
Patent NZ-546443-A (NZ)
Title: Poxvirus vector encoding retrovirus (eg HIV) and cytokine
Inventor: WARD LARRY D
IPC: A61K38/21
Filed: 2004-10-15
Abstract: Disclosed is a use of a recombinant vector comprising a sequence of nucleotides encoding a retrovirus antigen or a functional derivative, homolog, or part thereof, and a sequence of nucleotides encoding a cytokine or a functional derivative, homolog, or part thereof in the manufacture of a medicament for use in conjunction with interrupted anti-retroviral drug treatment to maintain or prolong a low retroviral load in a subject for a period of time, wherein said cytokine is selected from IFN-Gamma, IL-12, IL-2, TNF and IL-6 and said retrovirus antigen is encoded by a coding region selected from gag, env, pol and pro coding regions. The vector can also be used to prevent, reduce or delay viral rebound during interruption of anti-retroviral drug treatment and also reduce or alleviate one or more side effects of anti-retroviral drug therapy.
Patent NZ-546537-A (NZ)
Title: Heating device with thin heating boards
Inventor: CHEN CHING-SONG
Filed: 2006-04-10
Abstract: A heating device comprising: a case having a plurality of openings; a power line having a plurality of first connectors; a plurality of heating boards installed in the case at an equal distance and each heating board including a heating layer, the heating layer being sandwiched between two isolation plates, two wires connected to the heating layer and each wire having second connectors which are connected with the first connectors of the power line to connect the heating boards in parallel.
Patent NZ-554129-A (NZ)
Title: Quick release toilet seat hinge assembly
Inventor: VIERKANT ERICH C
IPC: A47K13/12
Filed: 2005-09-20
Abstract: Disclosed is a hinge assembly for connecting a toilet seat and cover to a rearward extension behind a toilet bowl. Two base members are permanently affixed to the extension in spaced fashion. Two hinge support members are provided to snap connect to the base members by virtue of flexible tabs on the base members interconnecting with side wall holes on the hinge supports. The hinge supports, seat and cover can be removed from the extension by squeezing the sides of the hinge support members, leaving only the bases attached to the extension. This facilitates cleaning.
Patent NZ-555743-A (NZ)
Title: Novel pharmaceutical composition useful for vaccines
Inventor: MOREAU MARINETTE
Filed: 2005-12-01
Abstract: Disclosed is a pharmaceutical composition comprising at least the mixture of at least one oil, at least one surfactant and an aqueous phase, itself comprising at least one active substance, said pharmaceutical composition being in the form of an oily isotrope (a dissolution of oil in water) rather than an emulsion. The composition is particularly suitable for use as an adjuvant for a vaccine.
Patent NZ-560714-A (NZ)
Title: Locking mechanism for coupling to pneumatic plugs to prevent theft using a padlock
Inventor: BLANCH DAVID
Filed: 2007-08-17
Abstract: Disclosed is a lock assembly (1) for locking onto a coupling plug (3). The lock assembly (1) includes a housing (2) for receiving the plug (3). The assembly (1) also includes an actuator (4) which is movable between a lock position and a release position. The lock assembly (1) also includes at least one detent (11) which is movable between an active position and an inactive position in response to movement of the actuator between the lock position and the release position. The lock assembly (1) also includes a locking means that when operable retains the actuator (4) in a lock position.
Patent NZ-567100-A (NZ)
Title: A bolt locking washer with a swagable locking plate tha grips the bolt head
Inventor: THRIFT PHIL
IPC: F16B37/14
Filed: 2006-09-19
Abstract: A locking cap for a bolt is disclosed. The locking cap has three parts, a washer (1), a locking plate (4) and a cap (11). The locking plate (4) and the cap (21) are connected so the cap (21) covers the bolt head (2) when the locking plate (4) is engaged with bolt head (2). A foldable tab (5) connects the cap (21) and locking plate (4) with the washer (1). In use the bolt shaft is passed through a hole in the washer (1) and the assembly is tightened to lock the washer (1) position. The cap (21) and locking plate (4) are then folded down to cover and engage the bolt head (2). As the maximum diameter of the bolt head (2) is larger than the hole in the locking plate (4), the locking plate (4) deforms to conform to the shape of the bolt head (2). This prevents further rotation of the bolt head (2) relative to the washer (1). The cap (21) then protects the swaged connection and the bolt head (2).
Patent NZ-569013-A (NZ)
Title: [(1H-indol-5-yl)-heteroaryloxy]-1-aza-bicyclo[3.3.1]nonanes as cholinergic ligands of the N-ACHR for the treatment of psychotic and neurodegenerative disorders
Inventor: FEUERBACH DOMINIK
IPC: A61K31/439
Filed: 2006-12-14
Abstract: The disclosure relates to 1-aza-bicycloalkyl derivatives of formula (I) wherein the substituents are as defined in the specification and to processes for their production to pharmaceutical compositions comprising them and to their use in the manufacture of a medicament for the treatment and/ or delay of progression of psychotic and neurodegenerative disorders. The disclosure particularly relates to 1-aza-bicycloalkyl derivatives of formula (I) selected from: (4S,5R)-4-[5-(1H-Indol-5-yl)-pyrimidin-2-yloxy]-1-azabicyclo[3.3.1]nonane; 5-{2-[(4S,5R)-(1-Aza-bicyclo[3.3.1]non-4-yl)oxy]-pyrimidin-5-yl}-1,3dihydro-indol-2-one; (4S,5R)-4-[6-(1H-Indol-5-yl)-pyridin-3-yloxy]-1 aza-bicyclo[3.3.1]nonane; (4S,5R)-4-[5-(1H-Indol-5-yl)-pyridin-2-yloxy]-1-aza-bicyclo[3.3.1]nonane; (4S,5R)-4-[6-(1H-Indol-5-yl)-pyridazin-3-yloxy]-1-aza-bicyclo[3.3.1]nonane; and 5-{6-[(4S,5R)-(1-Aza-bicyclo[3.3.1]non-4-yl)oxy]-pyridazin-3-yl}-1,3-dihydro-indol-2-one.
Patent NZ-577058-A (NZ)
Title: Compositions and methods for treating a neoplasm
Inventor: MASS ROBERT D
IPC: A61P35/00
Filed: 2007-05-04
Abstract: Use of an antagonist anti-VEGF antibody in the manufacture of a medicament for treating multiple myeloma in a patient relapsed from or refractory to bortezomib therapy.
Patent NZ-580642-A (NZ)
Title: Novel piperazine salts as d3/d2 antagonists
Inventor: AGAINE CSONGOR EVA
IPC: A61P25/00
Filed: 2008-05-13
Abstract: Disclosed herein are the monohydrochloride, dihydrochloride, monohydrobromide, maleate and methanesulphonate salts of the compound trans 4-{ 2-[4-(2,3-dichlorophenyl)-piperazine-1-yl]-ethyl} -N,N-dimethylcarbamoyl-cyclohexylamine and/or hydrates and/or solvates thereof, processes for the preparation and compositions comprising said compound salts. Such compounds are useful in the treatment of conditions requiring modulation of a dopamine receptor such as schizophrenia, schizo-affective disorders, cognitive impairment accompanying schizophrenia, mild to moderate cognitive deficits, dementia, psychotic states associated with dementia, psychotic depression, mania, paranoid and delusional disorders, dyskinetic disorders.
Patent NZ-582433-A (NZ)
Title: Lock for a sliding wing movable between an opening, closing and deadlock position
Inventor: JEFFREY CRAIG ROBERT
IPC: E05B63/04
Filed: 2008-06-05
Abstract: A lock is disclosed for a sliding wing comprising a pivoting lock tongue (14, 16) and an operating component (12) which can engage with the lock tongue (14, 16). The lock tongue is pivotable between a locking position (left) and an unlocking position (centre) to lock and unlock the door or window. The operating component (12) slides between a first position (left) and a second position (centre) and engages with the lock tongue (14, 16) so that linear movement of the operating component causes pivoting of the lock tongue between the unlocking and locking positions. In one embodiment a snib is operatively associated with the operating component (via apertures 125) to move it between the first and second positions. A drive component (18) engages with the operating component (12) and is movable between a lock opening position (left), a lock closing position (centre) and a deadlocking position (right). Movement of the drive component (18) into the deadlocking position causes the operating component (12) to be held in the second position so that it cannot be moved by the snib.
Patent NZ-585793-A (NZ)
Title: Compositions comprising a ginsenoside, a glycyrrhizically related acid and a jujuba cyclic adenosine monophosphate for treating depression and anxiety
Inventor: ZHANG ZUOGUANG
IPC: A61K36/258
Filed: 2007-11-30
Abstract: Disclosed is a pharmaceutical composition for treating at least one of a depression and an anxiety disorder, comprising: a ginsenoside consisting of an Rgl and an Rb 1; a glycyrrhizically related acid being one selected from a group consisting of a glycyrrhizic acid, a glycyrrhetinic acid and a combination thereof; and a jujuba cyclic adenosine monophosphate (Jujuba cAMP).
Patent NZ-586034-A (NZ)
Title: Modified human growth hormone polypeptides and their uses
Inventor: CHO HO SUNG
IPC: C12Q1/68
Filed: 2005-01-28
Abstract: Disclosed is a hormone composition comprising a growth hormone (GH) polypeptide comprising non-naturally encoded amino acids comprising a carbonyl functional group. Also disclosed is a method of producing the polypeptide and its use in a medicament.
Patent NZ-586998-A (NZ)
Title: Pack for tobacco industry products with volatile substance released from breakable capsule via permeable layer
Inventor: BLICK KEVIN
IPC: A24F25/02
Filed: 2009-02-05
Abstract: A pack (1) for tobacco industry products, comprises a housing defining an enclosure in which a plurality of tobacco industry products (4) can be accommodated, and a capsule (10) containing a substance such as flavouring substance, disposed in or on the pack, arranged to be opened manually such that, when opened, flavouring substance is released from the capsule and absorbed by tobacco industry products disposed in the pack, to refresh their flavour. The substance is passed by a permeable wick to selected locations in the tobacco product.
Patent NZ-589755-A (NZ)
Title: Vaccine composition useful for hpv and hepatitis b infections and a method for preparing the same
Inventor: ELLA KRISHNA MURTHY
IPC: A61K39/12
Filed: 2009-06-09
Abstract: Patent No. 589755 Disclosed is an immunogenic composition for prophylaxis and treatment against any known serotype of human papillomavirus (HPV) and hepatitis B infection in humans, wherein the immunogenic composition consists of complete or partial, mutant or variant polypeptides or specific T or B cell epitopes of the capsid protein L1 HPV antigens either as single sequence or in tandem repeats in chimeric fusions with hepatitis B surface antigen (HbsAg).
Patent NZ-590496-A (NZ)
Title: Hard surface cleaning composition
Inventor: GAUDREAULT ROSEMARY A
IPC: C11D3/43
Filed: 2011-01-13
Abstract: Disclosed is a hard surface cleaning solution consisting essentially of: a first organic acid comprising a carboxylic acid selected from the group consisting of lactic acid, glycolic acid, formic acid, citric acid and acetic acid; a second organic acid comprising a carboxylic acid different from the first organic acid and selected from the group consisting of gluconic acid, glycolic acid, formic acid, citric acid and acetic acid; a surfactant selected from the group consisting of amine oxides such as lauramine oxide; a solvent selected from the group consisting of ether alcohols such as propylene glycol (mono) butyl ether and wherein the solution has a pH of at least 2.0.
Patent NZ-590829-A (NZ)
Title: Plant growing assembly
Inventor: KERTZ MALCOLM GLEN
IPC: A01C23/00
Filed: 2009-07-28
Abstract: 590829 Disclosed is an apparatus for growing plants on a movable member in a growing room. The apparatus has a planar hanging member with an upper support member which attaches and hangs vertically from the movable member and supports the weight of the hanging member. The apparatus has a number of horizontal plant supports at different vertical heights on a face the hanging member. The apparatus has a nutrient delivery system with a conduit which forms a loop through a path which the hanging members travel. The nutrient delivery system sprays liquid nutrients onto the plants. The apparatus has a vessel to capture and recycle unused nutrients from the vessel to the loop, and a recycle conduit to recycle any unused nutrients.
Patent NZ-591174-A (NZ)
Title: Metered dose inhaler
Inventor: DAVIES JOHN HYWEL
IPC: A61K45/06
Filed: 2009-07-14
Abstract: 591174 The present invention relates to metered dose inhalers for the administration of active medicaments/propellants and excipients from pressurised aerosol cans. The invention provides a pMDI inhaler (20) comprising a pMDI canister (22), a vortex device, an integral horn (58) and a breath-activated mechanism (26, 28, 34, 66, 78). The canister (22) contains a formulation comprising a combination of an inhaled corticosteroid (ICS) such as fluticasone and a long-acting beta-agonist (LABA) such as sameterol. The combination of the vortex inhaler (20) with the asthma medication results in an increased lung absorption of the respirable dose.
Patent NZ-591843-A (NZ)
Title: 1h-benzimidazole-5-carboxamides as anti-inflammatory agents
Inventor: PFAU ROLAND
IPC: A61K31/4184
Filed: 2009-09-25
Abstract: There are provided compounds of formula (I) and their use, wherein R1, R6, R8, Q2, Q3, Q3a, Q4, L and A have meanings given in the description, and pharmaceutically-acceptable salts thereof, which compounds are useful in the treatment of diseases in which inhibition of the activity of a member of the MAPEG family is desired and/or required, and particularly in the treatment of inflammation and/or cancer. Examples of diseases treated: asthma, chronic obstructive pulmonary disease, pulmonary fibrosis, inflammatory bowel disease, irritable bowel syndrome, pain, inflammatory pain, fever, migraine, headache, low back pain, fibromyalgia, a myofascial disorder, a viral infection, a bacterial infection, a fungal infection, dysmenorrhea, a burn, a surgical or dental procedure, a malignancy, hyperprostaglandin E syndrome, classic Bartter syndrome, atherosclerosis, gout, arthritis, osteoarthritis, juvenile arthritis, rheumatoid arthritis, rheumatic fever, ankylosing spondylitis, Hodgkin's disease, systemic lupus erythematosus, vasculitis, pancreatitis, nephritis, bursitis, conjunctivitis, iritis, scleritis, uveitis, wound healing, dermatitis, eczema, psoriasis, stroke, diabetes mellitus, a neurodegenerative disorder, an autoimmune disease, an allergic disorder, rhinitis, an ulcer, coronary heart disease, sarcoidosis, any other disease with an inflammatory component, osteoporosis, osteoarthritis, Paget's disease, a periodontal disease or a cancer. Examples of compounds of formula (I) include: 2-(6-Chloro-2-fluoro-3-methyl-phenylamino)-6-methoxy-N-(trans-4-trifluoromethyl-cyclohex-1-yl)-1-methyl-1H-benzimidazole-5-carboxamide, 2-(3,6-Dichloro-2-fluoro-phenylamino)-6-isopropoxy-N-(spiro[2.5]oct-6-yl)-1-methyl-1H-benzimidazole-5-carboxamide, 2-(6-Chloro-2-fluoro-3-methyl-phenylamino)-N-cyclohexyl-6-fluoro-1H-benzimidazole-5-carboxamide, 2-(6-Chloro-2-fluoro-3-methyl-phenylamino)-6-methoxy-N-(4,4-dimethyl-cyclohex-1-yl)-1-methyl-1H-benzimidazole-5-carboxamide, 2-(6-Chloro-2-fluoro-3-methyl-phenylamino)-6-methoxy-N-cyclohexyl-1- methyl-1H-benzimidazole-5-carboxamide 2-(2,3,5,6-tetrafluoro-phenylamino)-6-methoxy-N-(4,4-dimethyl-cyclohex-1-yl)-1-methyl-1H-benzimidazole-5-carboxamide, 2-(6-Chloro-2-fluoro-3-methyl-phenylamino)-N-(trans-4-trifluoromethyl-cyclohex-1-yl)-6-fluoro-1H-benzimidazole-5-carboxamide, 2-(5-Fluoro-2-trifluoromethyl-phenylamino)-N-(4-bromphenyl)-6-methoxy-1-methyl-1H-benzimidazol-5-carboxamide.
Patent NZ-591942-A (NZ)
Title: A rabbit model for evaluating vasomotor response which involves measurements of the central ear artery
Inventor: PARRY TOM JAY
IPC: A61K49/00
Filed: 2009-10-21
Abstract: Disclosed is a method for evaluating the effect of a compound on vasomotor response in vivo comprises the steps of administering said compound to a rabbit and measuring the diameter of the vessel lumen of a central ear artery of said rabbit in comparison with the baseline diameter of the vessel lumen of said central ear artery of said rabbit, said baseline diameter being measured prior to the administration of said compound.